Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
A-336 by KLUS Pharma for Thromboembolism: Likelihood of Approval
A-336 is under clinical development by KLUS Pharma and currently in Phase I for Thromboembolism. According to GlobalData, Phase I...